Suicide Clinical Trial - Treating PTSD in Patients With Borderline

Status Completed

Clinical Trial Summary

Individuals with borderline personality disorder (BPD) are the quintessential multi-problem patients, often presenting to treatment with numerous dysfunctional behaviors and comorbid diagnoses. Dialectical Behavior Therapy (DBT) is a comprehensive, cognitive-behavioral treatment for BPD that has been shown effective in reducing the primary problems it is designed to treat; namely, the frequency and severity of self-injurious and suicidal behavior, maintenance in treatment, and severe problems in living. However, the DBT treatment manual does not currently include a protocol specifying when or how to treat posttraumatic stress disorder (PTSD), a comorbid diagnosis that is prevalent in BPD patients and may maintain or exacerbate BPD criterion behaviors. Similarly, many of the existing treatment outcome studies for PTSD have excluded suicidal, substance abusing, and multiply diagnosed patients, thereby making it difficult to determine the generalizability of these approaches to individuals with BPD. The research proposed here is focused on the development of a protocol based on Prolonged Exposure therapy to treat PTSD in BPD patients that can be integrated into standard DBT, as well as the initial evaluation of this protocol's feasibility, acceptability, and efficacy. The treatment development and pilot testing process will occur in two phases, including measure development and standardization of the treatment protocol via clinical pre-testing (Phase 1); and pilot and feasibility testing of the intervention via a randomized controlled trial (RCT) comparing standard DBT + PTSD Protocol to standard DBT Only (Phase 2). Information gathered during the pilot RCT will be used to inform the design and conduct of a subsequent full-scale RCT. This research has the potential to significantly expand and improve upon the most empirically supported treatment currently available for BPD, while also demonstrating that exposure treatments for PTSD can be implemented safely and effectively in a BPD population.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01081314
Study type	Interventional
Source	University of Washington
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	August 2009
Completion date	May 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04127292` - Impact of Clinician Virtual Human Interaction Training in Emotional Self-Awareness on Patients Suicidal Ideation and Suicide Crisis Syndrome	N/A
Recruiting	`NCT06079853` - Nurse Suicide: Physiologic Sleep Health Promotion Trial	N/A
Recruiting	`NCT05423483` - Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents	Phase 2
Completed	`NCT03272048` - Identifying Effective Approaches to Counseling on Firearm Safety	N/A
Completed	`NCT05514587` - Meaning of Life Questionnaire (MLQ) in Patients Admitted to the Crisis Centre (MSVCAC)
Enrolling by invitation	`NCT05639426` - Preventing Youth Violence Through Building Equitable Communities	N/A
Completed	`NCT03703128` - Suicide in People Aged 45-60: A Case-control Psychological Autopsy Study
Completed	`NCT03646903` - Reducing Help-Seeking Stigma in Young Adults at Elevated Suicide Risk	N/A
Not yet recruiting	`NCT05558332` - Youth Nominated Support Team	N/A
Not yet recruiting	`NCT06349915` - A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents	N/A
Completed	`NCT02718248` - Ottawa Suicide Prevention in Men Pilot Study	N/A
Completed	`NCT02094898` - Ketamine for Depression and Suicide Risk	Phase 2
Completed	`NCT01594138` - Linguistic Characteristics of Suicidal Patients in the Emergency Department	N/A
Completed	`NCT01360736` - A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)	N/A
Completed	`NCT02228044` - Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment	N/A
Completed	`NCT00604097` - Preventing Youth Suicide in Primary Care: A Family Model	Phase 3
Completed	`NCT00387855` - An Evaluation of the SOS (Suicide Prevention) Program	N/A
Recruiting	`NCT03519802` - Evaluation of Cognitive Function in a Suicidal Crisis
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting	`NCT03030924` - Wearable Suicidal Early Warning System for Adolescents

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Treating PTSD in Patients With Borderline Personality Disorder

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms